Arun K. Kashyap, Ph.D., is the Senior Vice President of Oncology at Nitrase Therapeutics. Dr. Kashyap has more than 25 years of experience as a leading drug discovery and early development expert in the biotherapeutics industry. He was previously the Vice President of Research at Arch Oncology where he directed the strategy and operations of discovery and preclinical drug development. Additionally, he oversaw portfolio management and intellectual property contributions, as well as academic and industry collaborations. At Dren Bio, Dr. Kashyap was a senior member of the founding scientific team responsible for leading the research department in the discovery and validation of antibody targets. He served in a similar capacity at Compugen, where he provided strategic and operational leadership for their therapeutic pipeline and platform technologies, including overseeing a multifunctional research group managing antibody discovery and protein science. During his tenures at Protagonist Therapeutics and Sea Lane Biotechnologies, Dr. Kashyap led discovery and preclinical efforts aimed at technology development and pipeline expansion. Dr. Kashyap obtained his Ph.D. in Molecular, Cell and Developmental Biology at the University of California in Santa Cruz and his A.B. in Zoology at the University of California in Berkeley.